High-risk Tumor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas (NCT02130869) | St. Jude Children's Research Hospital | 2014-10-10 |
Track High-risk Tumor automatically
Every clearance here is in the API, with alerts when new ones post.